Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Base case results
| Non-prophylaxis | Palivizumab | Incremental palivizumab vs non-prophylaxis. | |
|---|---|---|---|
| QALYs | 5.19 | 5.26 | 0.0731 |
| COSTS | |||
| Total costs | €671.68 | €2,110.71 | €1,439.03 |
| Prophylaxis costs (pharmaceutical and administration) | €0.00 | €1,886.78 | €1,886.78 |
| Hospital related costs | €246.44 | €78.14 | €-168.30 |
| Recurrent wheezing management costs | €425.23 | €145.78 | €-279.45 |
| ICUR (€/QALY gained with palivizumab vs non-prophylaxis | 1,9697.69 | ||
ICUR: incremental cost utility ratio; QALY: quality adjusted life years
